2Pasquali R, Macor C, Vicennati V, et al. Effects of acute hyperinsulinemia ontestosterone serum concentration in adult obese and normal-weight men [J]. Metabolism,1997,46:526～ 529.
3Pugeat M, Crave JC, Toumiaire J, et al. Clinical utility of sex hormone-bindingglobulin measurement [J].Horm Res, 1996,45:148～155.
4Qin KN,Rosenfield RL. Role of cytochrome P450c17 in polycystic ovary syndrome[J].Mol cell Endocrinol, 1998, 145:111～121.
5Sir T, Castillo T, Calvill M, et al. Effects of mefformin on insulin resistance inobese and hyperandrogenic women [J]. Rev Med Chil, 1997,125:1457～1463.
6Nutilla P, Knuuti MJ, Maki M, et al. Gender and insulin sensitivity in the skeletalmuscle [J].Diabetes, 1995,44:31～36.
7Diarmond MP, Grainger D, Diamond MC, et al. Effects of methyltestosterone oninsulin secretion and sensitivity in women[J] .J Clin Endocrinol Metab, 1998,83:4420～4425.
8Dernan RJ.Effects of sex steroids on women′s health:implication for pratitioners[J]. Am J Med, 1995,98:137～143.
9Moghetti P,Tosi F, Castello R, et al. The insulin resistance in women withhyperandrpgenism is partially reversed by anti-androgen treatment: evidence that androgenimpair insulin action in women [J] .J Clin Endocrinol Metab, 1996,8:952～ 960.
10Diamanti KE, Mitrakou A, Hennes M, et al. Insulin sensitivity and antiandrogenictherapy in women with polycystic ovary syndrome [J]. Metabolism, 1995,44:525～531.
10Diamomd MP,Grainser D,Diamond MC,a aL Effects of methyltestceterone on insulin secretion and sensitivity in women [J]. J Clin Endocrinol Metab, 1998; 83 ; 4420-4425.
